S02.9 · Healthcare & Life Sciences
A concentrated, MLR-capped US insurance market where AI claims automation is narrowing the network-scale advantage of the largest payers.
Payer, health insurance and managed care anchors on roughly $1.4-1.5T in US private health insurance spending (2023 actual, CMS NHE). Global health insurance estimates of $2.5-3T (2025E, Precedence Research) deserve caution — scope is inconsistent across reports, and the figure mixes fundamentally different payer systems. Growth is projected at 6-8% forward, led by Medicare Advantage expansion and premium inflation. The structural read is simple: margin is regulated, the top is concentrated, and when regulation caps margin and scale is already taken, competitive intensity goes vertical.
CMS NHE growth ran 5-6% historically, 6-8% projected forward. The US structure — employer-sponsored coverage, ACA exchange plans, Medicare Advantage and Medicaid managed care — differs fundamentally from single-payer and social-insurance systems elsewhere, which limits how comparable US M&A activity is to international peers. Concentration is high: the top 5 US payers — UnitedHealth, Elevance, CVS/Aetna, Cigna and Centene/Humana — hold roughly 45-50% of covered lives between them.
Providers and PBMs sit upstream; employers, government payers (CMS and state Medicaid) and individual members downstream. Medical loss ratio (MLR) regulation — typically an 80-85% floor on claims payout — caps what a payer keeps from each premium dollar. That cap is why scale, in the form of risk-pooling and network-negotiation leverage, is the primary lever left for improving economics. CMS star ratings and risk adjustment gate the rest, determining how a plan is reimbursed for the population it covers.
Prior authorization, claims adjudication and risk-adjustment coding are being handed to agentic AI — a direct compression of the claims-processing and administrative cost line, and the one component a payer still controls once medical cost and the MLR floor are fixed. Claims automation is already underway. The structural effect cuts against the incumbents: AI-driven utilization management tools that previously required in-house scale to build are now accessible to smaller payers, narrowing part of the competitive gap with the top 5.
The vertical move is where new economics live. A payer that also owns pharmacy benefit management and provider assets captures margin at multiple points in the value chain rather than one — PBM and provider vertical integration is expansionary, growing the book of economics rather than defending the existing insurance book. Care-management and digital-health technology plays defense, aimed at controlling medical cost trend rather than growing membership. AI-driven risk stratification at scale is a 2-5 year horizon.